Is screening for breast cancer with mammography justifiable? (Q30839166)

27 June 2017

0 references

Is screening for breast cancer with mammography justifiable? (English)

1 reference

27 June 2017

main subject

breast cancer screening

0 references

0 references

1 reference

1

Peter C Gøtzsche

0 references

author name string

Ole Olsen

series ordinal

2

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

27 June 2017

1 reference

27 June 2017

volume

355

1 reference

27 June 2017

issue

9198

1 reference

27 June 2017

page(s)

129-134

1 reference

Breast screening in women aged 40-49 years: what next?

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical Trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Breast cancer screening with mammography: overview of Swedish randomised trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Evaluation of Periodic Breast Cancer Screening With Mammography

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Impact of efforts to increase participation in repetitive screenings for early breast cancer detection.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

An analysis of the mortality effect in a breast cancer screening study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Screening: assessment of current studies

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Evidence on screening for breast cancer from a randomized trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

The Edinburgh randomised trial of screening for breast cancer: description of method

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

The Canadian National Breast Screening Study: a perspective on criticisms

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

The Canadian National Breast Screening Study: update on breast cancer mortality.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Randomized study of mammography screening — preliminary report on mortality in the stockholm trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Effects of repeated mammographic screening on breast cancer stage distribution. Results from a randomised study of 92 934 women in a Swedish county.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Breast cancer screening with mammography

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Screening mammography

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Efficacy of screening mammography. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

On being the right size: a reappraisal of mammography trials in Canada and Sweden

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

Ten-year risk of false positive screening mammograms and clinical breast examinations.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(99)06065-1

7 January 2021

10.1016/S0140-6736(99)06065-1

Identifiers

DOI

1 reference

27 June 2017

1 reference